Viewing nowTelmisartan Tablet 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 201901888 · Approved 2019.03.28 · Insurance code 694002280
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication is used for patients with essential hypertension and effectively controls blood pressure. Additionally, it helps reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients aged 55 and older with a high risk of major cardiovascular diseases. It is particularly suitable for patients with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attacks, or those with high-risk diabetes resulting in end-organ damage. It is used to enhance cardiovascular health and prevent complications.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective for some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The effect of doses below 80 mg in reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to individuals allergic to this medication or its components, pregnant women or those who might become pregnant, nursing mothers, patients with severe liver impairment, patients with hereditary angioedema, or patients with diabetes or moderate to severe kidney impairment. Caution should be exercised when administering to elderly patients, patients with hyperkalemia, mild to moderate liver impairment, heart valve disease, ischemic heart disease, gastrointestinal disease, renal artery hypertension, or severe kidney impairment. During treatment with this medication, various adverse reactions such as hypotension, hyperkalemia, worsening of kidney function, angioedema, liver dysfunction, interstitial lung disease, and rhabdomyolysis may occur, so immediate consultation with medical personnel is necessary if symptoms arise. Particularly, if there is a rapid drop in blood pressure or symptoms such as dizziness, fainting, shortness of breath, or swelling of the face or lips occur, immediate treatment should be sought. This medication may enhance the blood pressure-lowering effect when taken with other antihypertensive medications, so caution is required, and kidney function or electrolyte levels should be frequently monitored when taken with specific drugs. It is advisable to halt this medication at least 24 hours before any surgical procedure. This medication contains sorbitol, which is not suitable for patients with fructose intolerance. Caution is advised when driving or operating machinery due to the possibility of dizziness or fainting. This medication is not recommended for children or adolescents under 18 as safety and effectiveness have not been established. In cases of overdose, hypotension, dizziness, and acute renal failure may occur, necessitating immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It should also be kept at room temperature, between 1 to 30 degrees Celsius, to maintain its efficacy.
White or almost white, biconvex round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.